Mandhair HK, Radpour R, Westerhuis M, Banz Y, et al. Analysis of autophagy in DLBCL reveals subtype-specific differences and the preferential targeting of ULK1 inhibition in GCB-DLBCL provides a rationale as a new therapeutic approach. Leukemia 2024;38:424-429.
PMID: 38263431